Minerva Surgical, Inc. Common Stock
UTRS
UTRS was delisted on the 28th of December, 2023.
20 hedge funds and large institutions have $31.2M invested in Minerva Surgical, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 20 → 20 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
34% less capital invested
Capital invested by funds: $47.1M → $31.2M (-$16M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LM
Luminus Management
Houston,
Texas
|
+$600K |
| 2 |
LWM
Lyell Wealth Management
Menlo Park,
California
|
+$111K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$68.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$35.1K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$38 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$883K |
| 2 |
RI
RTW Investments
New York
|
-$390K |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$352K |
| 4 |
AIC
AWM Investment Company
New York
|
-$299K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$187K |
UTRS Hedge Fund Activity: Q3 2022 in Review
20 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Minerva Surgical, Inc. Common Stock (UTRS) for Q3 2022, worth a combined $31.2M — down 34% from $47.1M a quarter earlier.
Fund positioning in UTRS was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 6 trimmed.
The largest buyer was Luminus Management, adding an estimated $600K. The largest seller was Fidelity Investments, cutting an estimated $883K.
- 20 institutional investors held Minerva Surgical, Inc. Common Stock (UTRS) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $31.2M of Minerva Surgical, Inc. Common Stock stock for Q3 2022, down 34% quarter-over-quarter.
- 2 funds opened new Minerva Surgical, Inc. Common Stock positions in Q3 2022 and 2 closed out, a net change of 0 holders.
- The largest Minerva Surgical, Inc. Common Stock buyer in Q3 2022 was Luminus Management, an estimated $600K added.
- The largest Minerva Surgical, Inc. Common Stock seller in Q3 2022 was Fidelity Investments, an estimated $883K sold.
Based on aggregated 13F filings for Q3 2022.